How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries

How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries

We conducted research to assess hospital pharmacists’ familiarity with/interpretation of data requirements for the different regulatory approval frameworks and the impact of this on their approach to substitution in the formulary. The online questionnaire included a small molecule (acetylsalicylic a...

Full description

Bibliographic Details
Main Authors:	Natalia Sofia, Stefan Mühlebach, Umberto M. Musazzi, Rani Khatib, José Manuel Martinez Sesmero, Hans-Peter Lipp, Jacqueline Surugue, Tiziana Di Francesco, Beat Flühmann
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Pharmaceutics
Subjects:	drug substitution hospital formulary hospital pharmacy hybrid approval pathway nanomedicines nanosimilars
Online Access:	https://www.mdpi.com/1999-4923/13/7/1010

Similar Items

Nanomedicines and Nanosimilars—Why a Robust Centralised Regulatory Framework Is Essential to Enhance Patient Safety
by: Michael P. Isles
Published: (2022-02-01)

Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures
by: Alefan Q, et al.
Published: (2019-12-01)

SUITABILITY OF ANTIBIOTICS USE TOWARDS FORMULARY BEFORE AND DURING THE JKN IMPLEMENTATION AT UGM HOSPITAL YOGYAKARTA
by: Annisa Pungki Mawardani, et al.
Published: (2021-11-01)

Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine
by: Amy E. Barton, et al.
Published: (2022-01-01)

Financial management for health-system pharmacists /
by: Wilson, Andrew L, et al.
Published: (2009)

Academic Influence of the Pharmacy Department of Peking Union Medical College Hospital from 1921 to 1951
by: ZHU Zhu, et al.
Published: (2021-09-01)

Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review
by: Holly Sheldon, et al.
Published: (2022-06-01)

Progress in the search for blood substitutes, part 1 Preparations currently used in haemotherapy as an indicator of new drug development
by: Waldemar Grzegorzewski, et al.
Published: (2022-10-01)

The use of special approval medicines among pediatric patients in a tertiary care hospital: A reality check
by: Shamala Balan, et al.
Published: (2022-12-01)

Stable nanoemulsions : self-assembly in nature and nanomedicine /
by: D'Arrigo, Joseph S.
Published: (c201)

Long-Term Care medicines formularies: any reasons for pharmacists’ concern?
by: João Rafael Gonçalves, et al.
Published: (2023-08-01)

Consumption of systemic antibiotics in India in 2019
by: Shaffi Fazaludeen Koya, et al.
Published: (2022-09-01)

Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool
by: Lim TM, et al.
Published: (2012-09-01)

Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group
by: Raquel Vázquez-Mourelle, et al.
Published: (2019-07-01)

The Role of Pharmacists in Strengthening the Health System in Nigeria
by: Habeebullah Oladipo, et al.
Published: (2022-06-01)

Hospital and Community Pharmacists’ Views of and Perspectives on the Establishment of an Intraprofessional Collaboration in the Transition of Care for Newly Discharged Patients
by: Laura V.J. Lech, et al.
Published: (2020-08-01)

The Concept of Pharmacy Ethics and the Examples of Ethical Dilemmas Encountered by Pharmacists in the Asir Region, Saudi Arabia: A Qualitative Study
by: Orayj K, et al.
Published: (2022-05-01)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021-09-01)

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
by: Isabelle Arnet, et al.
Published: (2021-12-01)

Prescriptions Conformity with National Formulary: A Literature Review to Explore the Need for Pharmaceutical Cost Containment
by: Skarayadi Oskar, et al.
Published: (2023-01-01)

Developing a pharmacist-led intervention to provide transitional pharmaceutical care for hospital discharged patients: A collaboration between hospital and community pharmacists
by: Laura Victoria Jedig Lech, et al.
Published: (2022-09-01)

The Need to Strengthen the Role of the Pharmacist in Sri Lanka: Perspectives
by: M.H.F. Sakeena, et al.
Published: (2019-06-01)

EDUCATIONAL TUTORIALS ON THE HOSPITAL PHARMACIST'S RECORD IN THE PATIENT'S MEDICAL RECORDS
by: Émilin Dreher de Lima, et al.
Published: (2022-02-01)

Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand
by: Anke-Peggy Holtorf, et al.
Published: (2021-12-01)

Nanomedicine /
by: Hutto, Madelynn, author 647998
Published: (2012)

Pharmacist-Managed Therapeutic Drug Monitoring Programs within Australian Hospital and Health Services—A National Survey of Current Practice
by: Paul Firman, et al.
Published: (2022-10-01)

Correspondence to article "Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain"
by: David Gomez
Published: (2021-05-01)

Lecture 2—What Is a Formulary, Anyway? (Or the Cliff Notes Version of Drug Stewardship and Expense Control)
by: Richard H. Parrish
Published: (2018-07-01)

What Is a Formulary, Anyway? Part 2
by: Richard H. Parrish
Published: (2018-07-01)

The clinical nanomedicine handbook /
by: Brenner, Sara, 1980- editor
Published: (2014)

Nanomedicine and Laser Medicine /
by: Wolford, Marianela, author 647997, et al.
Published: (2012)

Medicine Shortages in Serbia: Pharmacists’ Standpoint and Potential Solutions for a Non-EU Country
by: Nataša Jovanović Lješković, et al.
Published: (2021-03-01)

Perception of pharmacists regarding human resources, training, and development of a national hospital pharmacy: a preliminary report on Basel Statements
by: Bruna Gabriela Rocha, et al.
Published: (2022-08-01)

An Integrated Multidisciplinary Circuit Led by Hospital and Community Pharmacists to Implement Clopidogrel Pharmacogenetics in Clinical Practice
by: Joan Francesc Mir, et al.
Published: (2023-04-01)

Pharmacists' viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan
by: Nabeel Khan, et al.
Published: (2020-07-01)

Impacts from the implementation of a Novel Clinical Pharmacist Training Program in Changsha, Hunan Province, China
by: Ping Xu, et al.
Published: (2018-05-01)

Substitution of Hospital Care with Primary Care: Defining the Conditions of Primary Care Plus
by: Sofie Johanna Maria van Hoof, et al.
Published: (2016-04-01)

Implementation of vertical clinical pharmacist service on venous thromboembolism prophylaxis in hospitalized medical patients
by: Celina Setsuko Haga, et al.

Nanomedicine in Diagnostics /
by: Rozlosnik, Noemi, editor 551496
Published: (2012)

Polymers in nanomedicine /
by: Kunugi, Shigeru, et al.
Published: (c201)